IBI112
Drug timelines are a Plus or Pro feature.
6 regulatory and trial events tracked for IBI112, covering 2024-01-25 to 2025-12-22. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Evaluate Efficacy and Safety of IBI112 in Adolescent Participants With Moderate to Severe Plaque Psoriasis [Phase 3]